Sara Mangsbo
Corporate Officer/Principal at ULTIMOVACS ASA
Profile
Sara Mangsbo is the founder of Immuneed AB, where she holds the title of Director & Chief Scientific Officer since 2014.
She is also the founder of Strike Pharma AB, where she holds the title of Chief Scientific Officer & Director since 2020.
Dr. Mangsbo is also the founder of VivoLogica AB.
Currently, she is the Chief Innovation Officer at Ultimovacs ASA.
Sara Mangsbo active positions
Companies | Position | Start |
---|---|---|
ULTIMOVACS ASA | Corporate Officer/Principal | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Founder | 2013-12-31 |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Founder | 2020-12-09 |
Former positions of Sara Mangsbo
Companies | Position | End |
---|---|---|
VivoLogica AB
VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Private companies | 3 |
---|---|
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Health Technology |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
VivoLogica AB
VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Technology Services |
- Stock Market
- Insiders
- Sara Mangsbo